Antiplasmodial and trypanocidal activity of violacein and deoxyviolacein produced from synthetic operons.
View / Open Files
Authors
Tavella, Tatyana A
Krogh, Renata
Stokes, Jamie E
Roberts, Annabelle
Ajioka, James
Spring, David R
Andricopulo, Adriano D
Costa, Fabio TM
Oliver, Stephen G
Publication Date
2018-04-11Journal Title
BMC Biotechnol
ISSN
1472-6750
Publisher
Springer Science and Business Media LLC
Volume
18
Issue
1
Pages
22
Language
eng
Type
Article
Physical Medium
Electronic
Metadata
Show full item recordCitation
Bilsland, E., Tavella, T. A., Krogh, R., Stokes, J. E., Roberts, A., Ajioka, J., Spring, D. R., et al. (2018). Antiplasmodial and trypanocidal activity of violacein and deoxyviolacein produced from synthetic operons.. BMC Biotechnol, 18 (1), 22. https://doi.org/10.1186/s12896-018-0428-z
Abstract
BACKGROUND: Violacein is a deep violet compound that is produced by a number of bacterial species. It is synthesized from tryptophan by a pathway that involves the sequential action of 5 different enzymes (encoded by genes vioA to vioE). Violacein has antibacterial, antiparasitic, and antiviral activities, and also has the potential of inducing apoptosis in certain cancer cells. RESULTS: Here, we describe the construction of a series of plasmids harboring the complete or partial violacein biosynthesis operon and their use to enable production of violacein and deoxyviolacein in E.coli. We performed in vitro assays to determine the biological activity of these compounds against Plasmodium, Trypanosoma, and mammalian cells. We found that, while deoxyviolacein has a lower activity against parasites than violacein, its toxicity to mammalian cells is insignificant compared to that of violacein. CONCLUSIONS: We constructed E. coli strains capable of producing biologically active violacein and related compounds, and propose that deoxyviolacein might be a useful starting compound for the development of antiparasite drugs.
Keywords
Antiparasitic, Deoxyviolacein, Escherichia coli, Plasmodium falciparum, Synthetic operon, Trypanosoma cruzi, Violacein, Animals, Antimalarials, Antineoplastic Agents, COS Cells, Chlorocebus aethiops, Escherichia coli, Hep G2 Cells, Humans, Indole Alkaloids, Indoles, Metabolic Engineering, Operon, Plasmids, Plasmodium falciparum, Spiro Compounds, Trypanocidal Agents, Trypanosoma cruzi
Sponsorship
Royal Society (WM150022)
Biotechnology and Biological Sciences Research Council (BB/L014130/1)
Biotechnology and Biological Sciences Research Council (BB/F008228/1)
Bill & Melinda Gates Foundation (OPP1087646)
Identifiers
External DOI: https://doi.org/10.1186/s12896-018-0428-z
This record's URL: https://www.repository.cam.ac.uk/handle/1810/280482
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk